Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin
  
Deal Watch 2021
• Source: Shutterstock

More from Deal Watch

More from Strategy